Literature DB >> 12080224

Expression of e-cadherin and catenins in early gastric cancer.

Young-Eun Joo1, Jong-Sun Rew, Sung-Kyu Choi, Hee-Seung Bom, Chang-Soo Park, Sei-Jong Kim.   

Abstract

E-cadherin and its associated cytoplasmic proteins including alpha-, beta-, and gamma-catenin play a pivotal role in the maintenance of normal tissue architecture and the suppression of cancer invasion. The purpose of this study was to evaluate the expression of E-cadherin and alpha-, beta-, and gamma-catenin in a larger sample of early gastric cancer, and to examine the relation between these expressions and various clinicopathologic variables. The expression of E-cadherin and alpha-, beta-, and gamma-catenin was investigated using immunohistochemical technique with formalin-fixed, paraffin-embedded tissue specimens obtained from 108 patients who underwent surgery for early gastric cancer. In the gastric mucosa of noncancerous areas, epithelial cells showed equally strong membranous expression of E-cadherin and alpha-, beta-, and gamma-catenin proteins at the cell-cell boundaries. Reduced expression of E-cadherin and alpha-, beta-, and gamma-catenin was demonstrated in 43.5%, 39.8%, 42.6%, and 50% of cancer tissues, respectively. Whereas 34 tumors (31.5%) displayed preserved expression of all four E-cadherin-catenin complex components, 21 tumors (19.4%) displayed reduced expression of all components of this complex. Reduced expression of E-cadherin and alpha- and gamma-catenin occurred more frequently in diffuse than in intestinal types of cancer, and decreased expression of E-cadherin and alpha-, beta-, and gamma-catenin correlated with poor differentiation. The expression of E-cadherin and beta- and gamma-catenin did not correlate with the patient's age, gender, tumor size, location, macroscopic type, depth of invasion, or lymph node metastasis. Only reduced expression of alpha-catenin correlated with lymph node metastasis. Reduced expression of all four E-cadherin-catenin complex components correlated with poorly differentiated and diffuse-type cancers, but not with the patient's age, gender, tumor size, location, macroscopic type, depth of invasion, or lymph node metastasis. These results suggest that dysfunction of the E-cadherin-catenin complex occurs in an early stage of carcinogenesis, playing a crucial role in disruption of tissue architecture and loss of differentiation in early gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12080224     DOI: 10.1097/00004836-200207000-00009

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  11 in total

1.  Expression of E-cadherin in gastric carcinoma and its correlation with lymph node micrometastasis.

Authors:  Ze-Yu Wu; Wen-Hua Zhan; Jing-Hua Li; Yu-Long He; Jian-Ping Wang; Ping Lan; Jun-Sheng Peng; Shi-Rong Cai
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

2.  Relationship between beta-catenin expression and epithelial cell proliferation in gastric mucosa with intestinal metaplasia.

Authors:  Adriana Romiti; Angelo Zullo; Francesco Borrini; Ida Sarcina; Cesare Hassan; Simon Winn; Silverio Tomao; Aldo Vecchione; Sergio Morini; Pietro Mingazzini
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

3.  Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.

Authors:  Edaise M Silva; Maria D Begnami; José Humberto T G Fregnani; Adriane G Pelosof; Claudia Zitron; André L Montagnini; Fernando Augusto Soares
Journal:  Gastric Cancer       Date:  2008-09-30       Impact factor: 7.370

4.  Predictable factors for lymph node metastasis in early gastric cancer analysis of clinicopathologic factors and biological markers.

Authors:  Yi-Wei Wang; Mei-Ling Zhu; Rui-Fen Wang; Wen-Ji Xue; Xue-Ru Zhu; Li-Feng Wang; Lei-Zhen Zheng
Journal:  Tumour Biol       Date:  2016-01-05

5.  β-Catenin serves as a clutch between low and high intercellular E-cadherin bond strengths.

Authors:  Saumendra Bajpai; Yunfeng Feng; Denis Wirtz; Gregory D Longmore
Journal:  Biophys J       Date:  2013-11-19       Impact factor: 4.033

6.  The cadherin-catenin complex in nasopharyngeal carcinoma.

Authors:  H Galera-Ruiz; M J Ríos; R González-Cámpora; M de Miguel; M I Carmona; A M Moreno; Hugo Galera-Davidson
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-01-15       Impact factor: 2.503

7.  The cadherin-catenin complex in laryngeal squamous cell carcinoma.

Authors:  H Galera-Ruiz; M J Ríos-Moreno; R González-Cámpora; I Ortega; A Fernández; A García-Escudero; H Galera-Davidson
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-25       Impact factor: 2.503

8.  Pinocembrin suppresses TGF-β1-induced epithelial-mesenchymal transition and metastasis of human Y-79 retinoblastoma cells through inactivating αvβ3 integrin/FAK/p38α signaling pathway.

Authors:  Kun-Shiang Chen; Ming-Der Shi; Chi-Sheng Chien; Yuan-Wei Shih
Journal:  Cell Biosci       Date:  2014-08-12       Impact factor: 7.133

Review 9.  Levels of soluble E-cadherin in breast, gastric, and colorectal cancers.

Authors:  Ombretta Repetto; Paolo De Paoli; Valli De Re; Vincenzo Canzonieri; Renato Cannizzaro
Journal:  Biomed Res Int       Date:  2014-09-16       Impact factor: 3.411

10.  Overexpression of cytoplasmic β-catenin inhibits the metastasis of the murine osteosarcoma cell line LM8.

Authors:  Teruki Kidani; Atsushi Nakamura; Setsuya Kamei; Yoshiaki Norimatsu; Hiromasa Miura; Hiroshi Masuno
Journal:  Cancer Cell Int       Date:  2014-04-02       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.